Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy.

Yu, Anthony F; Dang, Chau T; Jorgensen, Justine; Moskowitz, Chaya S; DeFusco, Patricia; Oligino, Eric; Oeffinger, Kevin C; Liu, Jennifer E; Steingart, Richard M

Yu, Anthony F; Dang, Chau T; Jorgensen, Justine; Moskowitz, Chaya S; DeFusco, Patricia; Oligino, Eric; Oeffinger, Kevin C; Liu, Jennifer E; Steingart, Richard M.

Afiliação

Yu AF; Department of Medicine, Cardiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. yua3@mskcc.org.
Dang CT; Weill Cornell Medical College, New York, NY, USA. yua3@mskcc.org.
Jorgensen J; Department of Medicine, Cardiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Moskowitz CS; Weill Cornell Medical College, New York, NY, USA.
DeFusco P; Department of Medicine, Cardiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Oligino E; Department of Medicine, Cardiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
Oeffinger KC; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA.
Liu JE; Hartford Healthcare, Hartford, CT, USA.
Steingart RM; Hartford Healthcare, Hartford, CT, USA.

Cardiooncology ; 9(1): 13, 2023 Mar 09.

Article em En | MEDLINE | ID: mdl-36895062

Palavras-chave

Breast cancer; Cardio-oncology; Cardiotoxicity; Echocardiography

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Cardiooncology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google